This article argues that inequitable access to interventions capable of dramatically extending human lifespans would undermine individual and collective upkeep of civic virtue.
AMA J Ethics. 2025;27(12):E853-858. doi:
10.1001/amajethics.2025.853.
Despite legislative attention from Congress in the 1980s, diagnostic research into rare diseases is not lucrative enough to garner sufficient private funding.
AMA J Ethics. 2025;27(10):E743-749. doi:
10.1001/amajethics.2025.743.
Dr David A. Pearce joins Ethics Talk to discuss his article, coauthored with Dr Elena-Alexandra Tataru: “What Matters Ethically About How the UDN Has Changed Since Its Inception.”
Gabriella Aboulafia, MPP and Adrianna McIntyre, PhD, MPH, MPP
Medicaid provides health insurance for nearly half of children in the United States, but this coverage has been unstable because of redetermination requirements.
AMA J Ethics. 2025;27(9):E686-694. doi:
10.1001/amajethics.2025.686.